UBLCP1

Across TCGA pan-cancer cohorts, UBLCP1 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of UBLCP1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where UBLCP1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types UBLCP1 is over-expressed in tumor.

COAD, CCRCC, and HNSC are the cancer types where UBLCP1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBLCP1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	+0.422	<.001	11	view →
CCRCC	All	III,IV	+0.125	<.001	10	view →
HNSC	All	II,III,IV	+0.137	<.001	7	view →
LUAD	Female	All	+0.222	<.001	6	view →
LSCC	Male	All	+0.119	<.001	4	view →
PDAC	All	All	+0.146	.008	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

UBLCP1–COAD

Open the COAD breakdown →